Cone Beam CT Scanning in Lung and Bladder Cancer.
Study Details
Study Description
Brief Summary
To study changes in tumor and normal organ size and/or position which occur during a course of radiation treatments.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patient has biopsy proven limited stage SCLC
-
receiving radical concurrent chemoradiotherapy
-
no prior chest RT
-
no prior surgical resection of lung tumor
-
no prior chemotherapy
-
patients' lung tumors should be centrally-located to minimize the effect of respiratory motion
-
patient has biopsy proven TCC bladder
-
receiving radical concurrent chemoradiotherapy or RT alone
-
no prior chemotherapy
-
patient signs study-specific consent form
Exclusion Criteria:
-
mixed small cell and non small cell histology
-
patient not being treated with concurrent chemoradiotherapy
-
chemoradiotherapy given sequentially
-
previous chest RT
-
previous chemotherapy
-
prior surgical resection of lung mass
-
patient ineligible for pelvic RT
-
patient does not sign study consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Cross Cancer Institute | Edmonton | Alberta | Canada |
Sponsors and Collaborators
- AHS Cancer Control Alberta
- Cross Cancer Institute
Investigators
- Principal Investigator: Don Yee, MD, AHS Cancer Control Alberta
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- LU-11-0073